Clinical Trial Update: Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating time-of-day specified immunotherapy for advanced melanoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Melanoma
• Cutaneous Melanoma
• Melanoma
• Mucosal Melanoma

Drugs mentioned

• TIME Trial Immunotherapy (investigational)

Snippet

Sponsor: Emory University | Conditions: Advanced Acral Melanoma, Advanced Cutaneous Melanoma | Phase 2 | Status: RECRUITING